{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:04:45Z","timestamp":1793232285692,"version":"4.5.0"},"reference-count":188,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R21AG087888-01"],"award-info":[{"award-number":["R21AG087888-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R21AG087888-01"],"award-info":[{"award-number":["R21AG087888-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R21AG087888-01"],"award-info":[{"award-number":["R21AG087888-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R21AG087888-01"],"award-info":[{"award-number":["R21AG087888-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R21AG087888-01"],"award-info":[{"award-number":["R21AG087888-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R21AG087888-01"],"award-info":[{"award-number":["R21AG087888-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Alzheimer\u2019s disease is increasingly viewed as a breakdown of balanced excitation\u2013inhibition (E\/I) homeostasis layered atop classical proteinopathy. Restoring circuit-level neural excitation and inhibition is rapidly becoming a tractable therapeutic strategy, guiding trials of circuit-modulating drugs such as levetiracetam. To date, however, findings across species and modalities remain fragmented, and it is unclear how to contextualize AD-focused E\/I findings across scales and methodologies. Synthesizing over 150 studies of E\/I homeostasis in AD, we organize the results into several prevailing themes: excitatory\/inhibitory effects of amyloid and tau, whether hyperexcitation precedes amyloid plaque deposition, progressive oscillatory slowing (a shift of aggregate neural signal frequencies towards lower frequencies) as AD worsens, early preclinical hyperexcitation peaking in MCI and transitioning to hypoexcitation in AD, sex differences in E\/I trajectories,\n                    <jats:italic>APOE4<\/jats:italic>\n                    as a mediating factor, the contribution of neuroinflammation and metabolic dysfunction to E\/I imbalance, and E\/I-focused trials\/experiments, particularly involving levetiracetam. These dominant themes are interpreted in a framework of multidimensional E\/I homeostasis, rather than a single-axis imbalance. To support this integration, we first outline the microscale, mesoscale, and macroscale techniques used to assess E\/I in AD, ranging from patch clamping and extracellular recordings to EEG\/MEG and fMRI. By charting these multiscale E\/I shifts, our synthesis offers a unifying framework to guide future experimental work and accelerate the design of biomarker-driven trials of E\/I-targeted therapies in Alzheimer\u2019s disease.\n                  <\/jats:p>","DOI":"10.1038\/s41386-026-02334-0","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T17:24:02Z","timestamp":1768843442000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Excitation\u2013inhibition homeostasis in Alzheimer\u2019s disease: a selective multiscale review of mechanisms, sex differences, and therapeutic opportunities"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7828-6780","authenticated-orcid":false,"given":"Andrew P.","family":"Burns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica I.","family":"Duran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Fortel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5887-948X","authenticated-orcid":false,"given":"Orly","family":"Lazarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Bendlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Leow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"2334_CR1","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3233\/JAD-180141","volume":"64","author":"CR Beam","year":"2018","unstructured":"Beam CR, Kaneshiro C, Jang JY, Reynolds CA, Pedersen NL, Gatz M. Differences between women and men in incidence rates of dementia and Alzheimer\u2019s disease. J Alzheimers Dis. 2018;64:1077\u201383. https:\/\/doi.org\/10.3233\/JAD-180141.","journal-title":"J Alzheimers Dis"},{"key":"2334_CR2","doi-asserted-by":"publisher","first-page":"437","DOI":"10.31887\/DCNS.2016.18.4\/cepperson","volume":"18","author":"JL Podcasy","year":"2016","unstructured":"Podcasy JL, Epperson CN. Considering sex and gender in Alzheimer disease and other dementias. Dialog Clin Neurosci. 2016;18:437\u201346.","journal-title":"Dialog Clin Neurosci"},{"key":"2334_CR3","doi-asserted-by":"publisher","unstructured":"2024 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s & Dementia. 2024;20:3708\u2013821. https:\/\/doi.org\/10.1002\/alz.13809.","DOI":"10.1002\/alz.13809"},{"key":"2334_CR4","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr, Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimer\u2019s Dement. 2024;20:5143\u201369. https:\/\/doi.org\/10.1002\/alz.13859.","journal-title":"Alzheimer\u2019s Dement"},{"key":"2334_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388:9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948.","journal-title":"N Engl J Med"},{"key":"2334_CR6","doi-asserted-by":"publisher","first-page":"943","DOI":"10.17219\/acem\/171379","volume":"32","author":"M Kurkinen","year":"2023","unstructured":"Kurkinen M. Lecanemab (Leqembi) is not the right drug for patients with Alzheimer\u2019s disease. Adv Clin Exp Med. 2023;32:943\u20137. https:\/\/doi.org\/10.17219\/acem\/171379.","journal-title":"Adv Clin Exp Med"},{"key":"2334_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrn.2018.20","volume":"19","author":"L Muller","year":"2018","unstructured":"Muller L, Chavane F, Reynolds J, Sejnowski TJ. Cortical travelling waves: mechanisms and computational principles. Nat Rev Neurosci. 2018;19:255\u201368. https:\/\/doi.org\/10.1038\/nrn.2018.20.","journal-title":"Nat Rev Neurosci"},{"key":"2334_CR8","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1162\/netn_a_00269","volume":"6","author":"Y Tian","year":"2022","unstructured":"Tian Y, Tan Z, Hou H, Li G, Cheng A, Qiu Y, et al. Theoretical foundations of studying criticality in the brain. Netw Neurosci. 2022;6:1148\u201385. https:\/\/doi.org\/10.1162\/netn_a_00269.","journal-title":"Netw Neurosci"},{"key":"2334_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.conb.2013.10.008","volume":"25","author":"O Barak","year":"2014","unstructured":"Barak O, Tsodyks M. Working models of working memory. Curr Opin Neurobiol. 2014;25:20\u20134. https:\/\/doi.org\/10.1016\/j.conb.2013.10.008.","journal-title":"Curr Opin Neurobiol"},{"key":"2334_CR10","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/nn.3492","volume":"16","author":"S Lim","year":"2013","unstructured":"Lim S, Goldman MS. Balanced cortical microcircuitry for maintaining information in working memory. Nat Neurosci. 2013;16:1306\u201314. https:\/\/doi.org\/10.1038\/nn.3492.","journal-title":"Nat Neurosci"},{"key":"2334_CR11","doi-asserted-by":"publisher","unstructured":"Koolschijn RS, Shpektor A, Clarke WT, Ip IB, Dupret D, Emir UE, et al. Memory recall involves a transient break in excitatory-inhibitory balance. eLife. 2021;10. https:\/\/doi.org\/10.7554\/eLife.70071.","DOI":"10.7554\/eLife.70071"},{"key":"2334_CR12","doi-asserted-by":"publisher","first-page":"109640","DOI":"10.1016\/j.yebeh.2024.109640","volume":"152","author":"L Chen","year":"2024","unstructured":"Chen L, Yang W, Yang F, Yu Y, Xu T, Wang D, et al. The crosstalk between epilepsy and dementia: a systematic review and meta-analysis. Epilepsy Behav. 2024;152:109640. https:\/\/doi.org\/10.1016\/j.yebeh.2024.109640.","journal-title":"Epilepsy Behav"},{"key":"2334_CR13","doi-asserted-by":"publisher","unstructured":"Canitano R. Palumbi R. Excitation\/inhibition modulators in autism spectrum disorder: current clinical research. Front Neurosci. 2021;15. https:\/\/doi.org\/10.3389\/fnins.2021.753274.","DOI":"10.3389\/fnins.2021.753274"},{"key":"2334_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65500-4","volume":"10","author":"H Bruining","year":"2020","unstructured":"Bruining H, Hardstone R, Juarez-Martinez EL, Sprengers J, Avramiea AE, Simpraga S, et al. Measurement of excitation-inhibition ratio in autism spectrum disorder using critical brain dynamics. Sci Rep. 2020;10:9195. https:\/\/doi.org\/10.1038\/s41598-020-65500-4.","journal-title":"Sci Rep"},{"key":"2334_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-014-0189-0","volume":"11","author":"A El-Ansary","year":"2014","unstructured":"El-Ansary A, Al-Ayadhi L. GABAergic\/glutamatergic imbalance relative to excessive neuroinflammation in autism spectrum disorders. J Neuroinflamm. 2014;11:189. https:\/\/doi.org\/10.1186\/s12974-014-0189-0.","journal-title":"J Neuroinflamm"},{"key":"2334_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1034\/j.1601-183X.2003.00037.x","volume":"2","author":"JLR Rubenstein","year":"2003","unstructured":"Rubenstein JLR, Merzenich MM. Model of autism: increased ratio of excitation\/inhibition in key neural systems. Genes, Brain Behav. 2003;2:255\u201367. https:\/\/doi.org\/10.1034\/j.1601-183X.2003.00037.x.","journal-title":"Genes, Brain Behav"},{"key":"2334_CR17","doi-asserted-by":"publisher","unstructured":"Usc\u0103tescu LC, Hyatt CJ, Dunn J, Kronbichler M, Calhoun V, Corbera S, et al. Using the excitation\/inhibition ratio to optimize the classification of autism spectrum disorder and schizophrenia. medRxiv. Transl Psychiatry. 2025;15:234. https:\/\/doi.org\/10.1038\/s41398-025-03455-8.","DOI":"10.1038\/s41398-025-03455-8"},{"key":"2334_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1192\/bjp.2020.163","volume":"218","author":"K Heinze","year":"2021","unstructured":"Heinze K, Barron HC, Howes EK, Ramaswami M, Broome MR. Excitation and inhibition imbalance \u2013 a new therapeutic target for autism and psychosis? Br J Psychiatry: J Ment Sci. 2021;218:295. https:\/\/doi.org\/10.1192\/bjp.2020.163.","journal-title":"Br J Psychiatry: J Ment Sci"},{"key":"2334_CR19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00415-023-11890-0","volume":"271","author":"Y Abukhaled","year":"2024","unstructured":"Abukhaled Y, Hatab K, Awadhalla M, Hamdan H. Understanding the genetic mechanisms and cognitive impairments in Down syndrome: towards a holistic approach. J Neurol. 2024;271:87\u2013104. https:\/\/doi.org\/10.1007\/s00415-023-11890-0.","journal-title":"J Neurol"},{"key":"2334_CR20","doi-asserted-by":"publisher","unstructured":"Selten M, Bokhoven HV, Kasri NN. Inhibitory control of the excitatory\/inhibitory balance in psychiatric disorders. F1000Research. 2018;7:23. https:\/\/doi.org\/10.12688\/f1000research.12155.1","DOI":"10.12688\/f1000research.12155.1"},{"key":"2334_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae376","volume":"6","author":"N Corriveau-Lecavalier","year":"2024","unstructured":"Corriveau-Lecavalier N, Adams JN, Fischer L, Molloy EN, Maass A. Cerebral hyperactivation across the Alzheimer\u2019s disease pathological cascade. Brain Commun. 2024;6:fcae376. https:\/\/doi.org\/10.1093\/braincomms\/fcae376.","journal-title":"Brain Commun"},{"key":"2334_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-025-07876-5","volume":"8","author":"AP Burns","year":"2025","unstructured":"Burns AP, Fortel I, Zhan L, Lazarov O, Mackin RS, Demos AP, et al. Longitudinal excitation-inhibition balance altered by sex and APOE-\u03b54. Commun Biol. 2025;8:1\u20139. https:\/\/doi.org\/10.1038\/s42003-025-07876-5.","journal-title":"Commun Biol"},{"key":"2334_CR23","doi-asserted-by":"publisher","first-page":"e36011","DOI":"10.7554\/eLife.36011","volume":"8","author":"L Koelewijn","year":"2019","unstructured":"Koelewijn L, Lancaster TM, Linden D, Dima DC, Routley BC, Magazzini L, et al. Oscillatory hyperactivity and hyperconnectivity in young APOE-\u025b4 carriers and hypoconnectivity in Alzheimer\u2019s disease. Elife. 2019;8:e36011. https:\/\/doi.org\/10.7554\/eLife.36011.","journal-title":"Elife"},{"key":"2334_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13195-022-01041-4","volume":"14","author":"AM van Nifterick","year":"2022","unstructured":"van Nifterick AM, Gouw AA, van Kesteren RE, Scheltens P, Stam CJ, de Haan W. A multiscale brain network model links Alzheimer\u2019s disease-mediated neuronal hyperactivity to large-scale oscillatory slowing. Alzheimer\u2019s Res Ther. 2022;14:101. https:\/\/doi.org\/10.1186\/s13195-022-01041-4.","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"2334_CR25","doi-asserted-by":"publisher","first-page":"101372","DOI":"10.1016\/j.arr.2021.101372","volume":"69","author":"F Maest\u00fa","year":"2021","unstructured":"Maest\u00fa F, de Haan W, Busche MA, DeFelipe J. Neuronal excitation\/inhibition imbalance: core element of a translational perspective on Alzheimer pathophysiology. Ageing Res Rev. 2021;69:101372. https:\/\/doi.org\/10.1016\/j.arr.2021.101372.","journal-title":"Ageing Res Rev"},{"key":"2334_CR26","doi-asserted-by":"publisher","first-page":"9318","DOI":"10.3390\/ijms21239318","volume":"21","author":"S Toniolo","year":"2020","unstructured":"Toniolo S, Sen A, Husain M. Modulation of brain hyperexcitability: potential new therapeutic approaches in Alzheimer\u2019s disease. Int J Mol Sci. 2020;21:9318. https:\/\/doi.org\/10.3390\/ijms21239318.","journal-title":"Int J Mol Sci"},{"key":"2334_CR27","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.neuron.2019.11.011","volume":"105","author":"MCD Bridi","year":"2020","unstructured":"Bridi MCD, Zong FJ, Min X, Luo N, Tran T, Qiu J, et al. Daily oscillation of the excitation-inhibition balance in visual cortical circuits. Neuron. 2020;105:621\u2013.e4. https:\/\/doi.org\/10.1016\/j.neuron.2019.11.011.","journal-title":"Neuron"},{"key":"2334_CR28","doi-asserted-by":"publisher","first-page":"108609","DOI":"10.1016\/j.yebeh.2022.108609","volume":"129","author":"JM Hanke","year":"2022","unstructured":"Hanke JM, Schindler KA, Seiler A. On the relationships between epilepsy, sleep, and Alzheimer\u2019s disease: a narrative review. Epilepsy Behav. 2022;129:108609. https:\/\/doi.org\/10.1016\/j.yebeh.2022.108609.","journal-title":"Epilepsy Behav"},{"key":"2334_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s42466-021-00102-7","volume":"3","author":"I Silva","year":"2021","unstructured":"Silva I, Silva J, Ferreira R, Trigo D. Glymphatic system, AQP4, and their implications in Alzheimer\u2019s disease. Neurol Res Pract. 2021;3:5. https:\/\/doi.org\/10.1186\/s42466-021-00102-7.","journal-title":"Neurol Res Pract"},{"key":"2334_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53430-y","volume":"15","author":"Q Sun","year":"2024","unstructured":"Sun Q, Peng S, Xu Q, Weikop P, Hussain R, Song W, et al. Enhancing glymphatic fluid transport by pan-adrenergic inhibition suppresses epileptogenesis in male mice. Nat Commun. 2024;15:9600. https:\/\/doi.org\/10.1038\/s41467-024-53430-y.","journal-title":"Nat Commun"},{"key":"2334_CR31","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.3390\/biomedicines11082092","volume":"11","author":"KI Voumvourakis","year":"2023","unstructured":"Voumvourakis KI, Sideri E, Papadimitropoulos GN, Tsantzali I, Hewlett P, Kitsos D, et al. The dynamic relationship between the glymphatic system, aging, memory, and sleep. Biomedicines. 2023;11:2092. https:\/\/doi.org\/10.3390\/biomedicines11082092.","journal-title":"Biomedicines"},{"key":"2334_CR32","doi-asserted-by":"publisher","first-page":"4432","DOI":"10.1038\/s41380-025-03051-8","volume":"30","author":"TT Zhu","year":"2025","unstructured":"Zhu TT, Yang JJ, Hashimoto K. Noradrenergic modulation of glymphatic clearance: implications for neuropsychiatric disorders and mortality. Mol Psychiatry. 2025;30:4432\u20134. https:\/\/doi.org\/10.1038\/s41380-025-03051-8.","journal-title":"Mol Psychiatry"},{"key":"2334_CR33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.neuron.2017.11.028","volume":"97","author":"S Frere","year":"2018","unstructured":"Frere S, Slutsky I. Alzheimer\u2019s disease: from firing instability to homeostasis network collapse. Neuron. 2018;97:32\u201358. https:\/\/doi.org\/10.1016\/j.neuron.2017.11.028.","journal-title":"Neuron"},{"key":"2334_CR34","doi-asserted-by":"publisher","first-page":"111946","DOI":"10.1016\/j.celrep.2022.111946","volume":"42","author":"S Niraula","year":"2023","unstructured":"Niraula S, Doderer JJ, Indulkar S, Berry KP, Hauser WL, L'Esperance OJ, et al. Excitation-inhibition imbalance disrupts visual familiarity in amyloid and non-pathology conditions. Cell Rep. 2023;42:111946. https:\/\/doi.org\/10.1016\/j.celrep.2022.111946.","journal-title":"Cell Rep"},{"key":"2334_CR35","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/nn.4328","volume":"19","author":"JW Wu","year":"2016","unstructured":"Wu JW, Hussaini SA, Bastille IM, Rodriguez GA, Mrejeru A, Rilett K, et al. Neuronal activity enhances tau propagation and tau pathology in vivo. Nat Neurosci. 2016;19:1085\u201392. https:\/\/doi.org\/10.1038\/nn.4328.","journal-title":"Nat Neurosci"},{"key":"2334_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22742-8","volume":"12","author":"JC Lauterborn","year":"2021","unstructured":"Lauterborn JC, Scaduto P, Cox CD, Schulmann A, Lynch G, Gall CM, et al. Increased excitatory to inhibitory synaptic ratio in parietal cortex samples from individuals with Alzheimer\u2019s disease. Nat Commun. 2021;12:2603. https:\/\/doi.org\/10.1038\/s41467-021-22742-8.","journal-title":"Nat Commun"},{"key":"2334_CR37","doi-asserted-by":"publisher","unstructured":"Barbour AJ, Gourmaud S, Lancaster E, Li X, Stewart D, Irwin D, et al. Seizures exacerbate excitatory: inhibitory imbalance in Alzheimer\u2019s disease and 5XFAD mice. Brain. 2024;147:2169\u201384. https:\/\/doi.org\/10.1093\/brain\/awae126.","DOI":"10.1093\/brain\/awae126"},{"key":"2334_CR38","doi-asserted-by":"publisher","unstructured":"Fishell G, Kepecs A. Interneuron types as attractors and controllers. Annu Rev Neurosci. 2020; 43:1\u201330. https:\/\/doi.org\/10.1146\/annurev-neuro-070918-050421.","DOI":"10.1146\/annurev-neuro-070918-050421"},{"key":"2334_CR39","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nature12983","volume":"505","author":"A Kepecs","year":"2014","unstructured":"Kepecs A, Fishell G. Interneuron cell types: fit to form and formed to fit. Nature. 2014;505:318\u201326. https:\/\/doi.org\/10.1038\/nature12983.","journal-title":"Nature"},{"key":"2334_CR40","doi-asserted-by":"publisher","first-page":"e53569","DOI":"10.1371\/journal.pone.0053569","volume":"7","author":"L Leung","year":"2012","unstructured":"Leung L, Andrews-Zwilling Y, Yoon SY, Jain S, Ring K, Dai J, et al. Apolipoprotein E4 causes age- and sex-dependent impairments of hilar GABAergic interneurons and learning and memory deficits in mice. PLOS ONE. 2012;7:e53569. https:\/\/doi.org\/10.1371\/journal.pone.0053569.","journal-title":"PLOS ONE"},{"key":"2334_CR41","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00401-017-1674-1","volume":"133","author":"RJ Hatch","year":"2017","unstructured":"Hatch RJ, Wei Y, Xia D, G\u00f6tz J. Hyperphosphorylated tau causes reduced hippocampal CA1 excitability by relocating the axon initial segment. Acta Neuropathol. 2017;133:717\u201330. https:\/\/doi.org\/10.1007\/s00401-017-1674-1.","journal-title":"Acta Neuropathol"},{"key":"2334_CR42","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00401-012-1038-9","volume":"124","author":"JL Crimins","year":"2012","unstructured":"Crimins JL, Rocher AB, Luebke JI. Electrophysiological changes precede morphological changes to frontal cortical pyramidal neurons in the rTg4510 mouse model of progressive tauopathy. Acta Neuropathol. 2012;124:777\u201395. https:\/\/doi.org\/10.1007\/s00401-012-1038-9.","journal-title":"Acta Neuropathol"},{"key":"2334_CR43","doi-asserted-by":"publisher","first-page":"e14472","DOI":"10.7554\/eLife.14472","volume":"5","author":"NJ Sofroniew","year":"2016","unstructured":"Sofroniew NJ, Flickinger D, King J, Svoboda K. A large field of view two-photon mesoscope with subcellular resolution for in vivo imaging. eLife. 2016;5:e14472. https:\/\/doi.org\/10.7554\/eLife.14472.","journal-title":"eLife"},{"key":"2334_CR44","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.3390\/biology11111601","volume":"11","author":"AK Nietz","year":"2022","unstructured":"Nietz AK, Popa LS, Streng ML, Carter RE, Kodandaramaiah SB, Ebner TJ. Wide-field calcium imaging of neuronal network dynamics in vivo. Biology. 2022;11:1601. https:\/\/doi.org\/10.3390\/biology11111601.","journal-title":"Biology"},{"key":"2334_CR45","doi-asserted-by":"publisher","first-page":"eabf4588","DOI":"10.1126\/science.abf4588","volume":"372","author":"NA Steinmetz","year":"2021","unstructured":"Steinmetz NA, Aydin C, Lebedeva A, Okun M, Pachitariu M, Bauza M, et al. Neuropixels 2.0: a miniaturized high-density probe for stable, long-term brain recordings. Science. 2021;372:eabf4588. https:\/\/doi.org\/10.1126\/science.abf4588.","journal-title":"Science"},{"key":"2334_CR46","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nn.4504","volume":"20","author":"S Baillet","year":"2017","unstructured":"Baillet S. Magnetoencephalography for brain electrophysiology and imaging. Nat Neurosci. 2017;20:327\u201339. https:\/\/doi.org\/10.1038\/nn.4504.","journal-title":"Nat Neurosci"},{"key":"2334_CR47","doi-asserted-by":"publisher","first-page":"106380","DOI":"10.1016\/j.nbd.2023.106380","volume":"190","author":"M Kop\u010danov\u00e1","year":"2024","unstructured":"Kop\u010danov\u00e1 M, Tait L, Donoghue T, Stothart G, Smith L, Sandoval AAF, et al. Resting-state EEG signatures of Alzheimer\u2019s disease are driven by periodic but not aperiodic changes. Neurobiol Dis. 2024;190:106380. https:\/\/doi.org\/10.1016\/j.nbd.2023.106380.","journal-title":"Neurobiol Dis"},{"key":"2334_CR48","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1093\/brain\/awab430","volume":"145","author":"AI Wiesman","year":"2022","unstructured":"Wiesman AI, Murman DL, Losh RA, Schantell M, Christopher-Hayes NJ, Johnson HJ, et al. Spatially resolved neural slowing predicts impairment and amyloid burden in Alzheimer\u2019s disease. Brain. 2022;145:2177\u201389. https:\/\/doi.org\/10.1093\/brain\/awab430.","journal-title":"Brain"},{"key":"2334_CR49","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","volume":"55","author":"JJ Palop","year":"2007","unstructured":"Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer\u2019s disease. Neuron. 2007;55:697\u2013711. https:\/\/doi.org\/10.1016\/j.neuron.2007.07.025.","journal-title":"Neuron"},{"key":"2334_CR50","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1523\/JNEUROSCI.4152-10.2011","volume":"31","author":"ED Roberson","year":"2011","unstructured":"Roberson ED, Halabisky B, Yoo JW, Yao J, Chin J, Yan F, et al. Amyloid-\u03b2\/Fyn\u2013induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer\u2019s disease. J Neurosci. 2011;31:700\u201311. https:\/\/doi.org\/10.1523\/JNEUROSCI.4152-10.2011.","journal-title":"J Neurosci"},{"key":"2334_CR51","doi-asserted-by":"publisher","first-page":"12887","DOI":"10.1523\/JNEUROSCI.2107-13.2013","volume":"33","author":"SL DeVos","year":"2013","unstructured":"DeVos SL, Goncharoff DK, Chen G, Kebodeaux CS, Yamada K, Stewart FR, et al. Antisense reduction of tau in adult mice protects against seizures. J Neurosci. 2013;33:12887\u201397. https:\/\/doi.org\/10.1523\/JNEUROSCI.2107-13.2013.","journal-title":"J Neurosci"},{"key":"2334_CR52","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1093\/brain\/awz320","volume":"142","author":"S Pusil","year":"2019","unstructured":"Pusil S, L\u00f3pez ME, Cuesta P, Bru\u00f1a R, Pereda E, Maest\u00fa F. Hypersynchronization in mild cognitive impairment: the \u2018X\u2019 model. Brain. 2019;142:3936\u201350. https:\/\/doi.org\/10.1093\/brain\/awz320.","journal-title":"Brain"},{"key":"2334_CR53","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jneumeth.2008.04.012","volume":"172","author":"QH Zou","year":"2008","unstructured":"Zou QH, Zhu CZ, Yang Y, Zuo XN, Long XY, Cao QJ, et al. An improved approach to detection of amplitude of low-frequency fluctuation (ALFF) for resting-state fMRI: fractional ALFF. J Neurosci Methods. 2008;172:137\u201341. https:\/\/doi.org\/10.1016\/j.jneumeth.2008.04.012.","journal-title":"J Neurosci Methods"},{"key":"2334_CR54","doi-asserted-by":"publisher","unstructured":"Das S, Puthankattil SD. Functional connectivity and complexity in the phenomenological model of mild cognitive-impaired Alzheimer\u2019s disease. Front Comput Neurosci. 2022;16. https:\/\/doi.org\/10.3389\/fncom.2022.877912.","DOI":"10.3389\/fncom.2022.877912"},{"key":"2334_CR55","doi-asserted-by":"publisher","first-page":"e1002582","DOI":"10.1371\/journal.pcbi.1002582","volume":"8","author":"W de Haan","year":"2012","unstructured":"de Haan W, Mott K, van Straaten ECW, Scheltens P, Stam CJ. Activity-dependent degeneration explains hub vulnerability in Alzheimer\u2019s disease. PLOS Comput Biol. 2012;8:e1002582. https:\/\/doi.org\/10.1371\/journal.pcbi.1002582.","journal-title":"PLOS Comput Biol"},{"key":"2334_CR56","doi-asserted-by":"publisher","first-page":"e1005707","DOI":"10.1371\/journal.pcbi.1005707","volume":"13","author":"W de Haan","year":"2017","unstructured":"de Haan W, van Straaten ECW, Gouw AA, Stam CJ. Altering neuronal excitability to preserve network connectivity in a computational model of Alzheimer\u2019s disease. PLOS Comput Biol. 2017;13:e1005707. https:\/\/doi.org\/10.1371\/journal.pcbi.1005707.","journal-title":"PLOS Comput Biol"},{"key":"2334_CR57","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fncom.2019.00054","volume":"13","author":"L Stefanovski","year":"2019","unstructured":"Stefanovski L, Triebkorn P, Spiegler A, Diaz-Cortes MA, Solodkin A, Jirsa V, et al. Linking molecular pathways and large-scale computational modeling to assess candidate disease mechanisms and pharmacodynamics in Alzheimer\u2019s Disease. Front Comput Neurosci. 2019;13:54. https:\/\/doi.org\/10.3389\/fncom.2019.00054.","journal-title":"Front Comput Neurosci"},{"key":"2334_CR58","doi-asserted-by":"publisher","first-page":"6350","DOI":"10.1093\/cercor\/bhaa190","volume":"30","author":"I Fortel","year":"2020","unstructured":"Fortel I, Korthauer LE, Morrissey Z, Zhan L, Ajilore O, Wolfson O, et al. Connectome signatures of hyperexcitation in cognitively intact middle-aged female APOE-\u03b54 carriers. Cereb Cortex. 2020;30:6350\u201362. https:\/\/doi.org\/10.1093\/cercor\/bhaa190.","journal-title":"Cereb Cortex"},{"key":"2334_CR59","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.neuroimage.2018.08.033","volume":"183","author":"TH Alderson","year":"2018","unstructured":"Alderson TH, Bokde ALW, Kelso JAS, Maguire L, Coyle D. Metastable neural dynamics in Alzheimer\u2019s disease are disrupted by lesions to the structural connectome. NeuroImage. 2018;183:438\u201355. https:\/\/doi.org\/10.1016\/j.neuroimage.2018.08.033.","journal-title":"NeuroImage"},{"key":"2334_CR60","doi-asserted-by":"publisher","unstructured":"Arbabyazd L, Shen K, Wang Z, Hofmann-Apitius M, Ritter P, McIntosh AR, et al. Virtual connectomic datasets in Alzheimer\u2019s disease and aging using whole-brain network dynamics modelling. eNeuro. 2021;8. https:\/\/doi.org\/10.1523\/ENEURO.0475-20.2021.","DOI":"10.1523\/ENEURO.0475-20.2021"},{"key":"2334_CR61","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1111\/ejn.14666","volume":"52","author":"Y Cakir","year":"2020","unstructured":"Cakir Y. Hybrid modeling of alpha rhythm and the amplitude of low-frequency fluctuations abnormalities in the thalamocortical region and basal ganglia in Alzheimer\u2019s disease. Eur J Neurosci. 2020;52:2944\u201361. https:\/\/doi.org\/10.1111\/ejn.14666.","journal-title":"Eur J Neurosci"},{"key":"2334_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-230035","volume":"95","author":"I Fortel","year":"2023","unstructured":"Fortel I, Zhan L, Ajilore O, Wu Y, Mackin S, Leow A. Disrupted excitation-inhibition balance in cognitively normal individuals at risk of Alzheimer\u2019s disease. JAD. 2023;95:1\u201319. https:\/\/doi.org\/10.3233\/JAD-230035.","journal-title":"JAD"},{"key":"2334_CR63","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1109\/EMBC.2014.6943688","volume":"2014","author":"P Ghorbanian","year":"2014","unstructured":"Ghorbanian P, Ramakrishnan S, Ashrafiuon H. Stochastic coupled oscillator model of EEG for Alzheimer\u2019s disease. Annu Int Conf IEEE Eng Med Biol Soc. 2014;2014:706\u20139. https:\/\/doi.org\/10.1109\/EMBC.2014.6943688.","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"key":"2334_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s43856-025-00736-7","volume":"5","author":"G Li","year":"2025","unstructured":"Li G, Hsu LM, Wu Y, Bozoki AC, Shih YYI, Yap PT. Revealing excitation-inhibition imbalance in Alzheimer\u2019s disease using multiscale neural model inversion of resting-state functional MRI. Commun Med. 2025;5:1\u201321. https:\/\/doi.org\/10.1038\/s43856-025-00736-7.","journal-title":"Commun Med"},{"key":"2334_CR65","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13195-023-01349-9","volume":"15","author":"G Patow","year":"2023","unstructured":"Patow G, Stefanovski L, Ritter P, Deco G, Kobeleva X. for the Alzheimer\u2019s Disease Neuroimaging Initiative. Whole-brain modeling of the differential influences of amyloid-beta and tau in Alzheimer\u2019s disease. Alzheimer\u2019s Res Ther. 2023;15:210. https:\/\/doi.org\/10.1186\/s13195-023-01349-9.","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"2334_CR66","doi-asserted-by":"publisher","first-page":"e77850","DOI":"10.7554\/eLife.77850","volume":"11","author":"KG Ranasinghe","year":"2022","unstructured":"Ranasinghe KG, Verma P, Cai C, Xie X, Kudo K, Gao X, et al. Altered excitatory and inhibitory neuronal subpopulation parameters are distinctly associated with tau and amyloid in Alzheimer\u2019s disease. eLife. 2022;11:e77850. https:\/\/doi.org\/10.7554\/eLife.77850.","journal-title":"eLife"},{"key":"2334_CR67","doi-asserted-by":"publisher","first-page":"066019","DOI":"10.1088\/1741-2552\/ab4024","volume":"16","author":"SJ Ruiz-G\u00f3mez","year":"2019","unstructured":"Ruiz-G\u00f3mez SJ, Hornero R, Poza J, Maturana-Candelas A, Pinto N, G\u00f3mez C. Computational modeling of the effects of EEG volume conduction on functional connectivity metrics. Application to Alzheimer\u2019s disease continuum. J Neural Eng. 2019;16:066019. https:\/\/doi.org\/10.1088\/1741-2552\/ab4024.","journal-title":"J Neural Eng"},{"key":"2334_CR68","doi-asserted-by":"publisher","first-page":"e83970","DOI":"10.7554\/eLife.83970","volume":"12","author":"Y Sanz Perl","year":"2023","unstructured":"Sanz Perl Y, Fittipaldi S, Gonzalez Campo C, Moguilner S, Cruzat J, Fraile-Vazquez ME, et al. Model-based whole-brain perturbational landscape of neurodegenerative diseases. eLife. 2023;12:e83970. https:\/\/doi.org\/10.7554\/eLife.83970.","journal-title":"eLife"},{"key":"2334_CR69","doi-asserted-by":"publisher","first-page":"e12303","DOI":"10.1002\/trc2.12303","volume":"8","author":"P Triebkorn","year":"2022","unstructured":"Triebkorn P, Stefanovski L, Dhindsa K, Diaz-Cortes MA, Bey P, B\u00fclau K, et al. Brain simulation augments machine-learning-based classification of dementia. Alzheimers Dement. 2022;8:e12303. https:\/\/doi.org\/10.1002\/trc2.12303.","journal-title":"Alzheimers Dement"},{"key":"2334_CR70","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.3390\/brainsci13081133","volume":"13","author":"L Yang","year":"2023","unstructured":"Yang L, Lu J, Li D, Xiang J, Yan T, Sun J, et al. Alzheimer\u2019s disease: insights from large-scale brain dynamics models. Brain Sci. 2023;13:1133. https:\/\/doi.org\/10.3390\/brainsci13081133.","journal-title":"Brain Sci"},{"key":"2334_CR71","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.neuron.2023.11.014","volume":"112","author":"J Giorgio","year":"2024","unstructured":"Giorgio J, Adams JN, Maass A, Jagust WJ, Breakspear M. Amyloid induced hyperexcitability in default mode network drives medial temporal hyperactivity and early tau accumulation. Neuron. 2024;112:676\u2013686.e4. https:\/\/doi.org\/10.1016\/j.neuron.2023.11.014.","journal-title":"Neuron"},{"key":"2334_CR72","doi-asserted-by":"publisher","first-page":"fcac282","DOI":"10.1093\/braincomms\/fcac282","volume":"4","author":"G Moffat","year":"2022","unstructured":"Moffat G, Zhukovsky P, Coughlan G, Voineskos AN. Unravelling the relationship between amyloid accumulation and brain network function in normal aging and very mild cognitive decline: a longitudinal analysis. Brain Commun. 2022;4:fcac282. https:\/\/doi.org\/10.1093\/braincomms\/fcac282.","journal-title":"Brain Commun"},{"key":"2334_CR73","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1093\/brain\/awv007","volume":"138","author":"W Huijbers","year":"2015","unstructured":"Huijbers W, Mormino EC, Schultz AP, Wigman S, Ward AM, Larvie M, et al. Amyloid-\u03b2 deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression. Brain. 2015;138:1023\u201335. https:\/\/doi.org\/10.1093\/brain\/awv007.","journal-title":"Brain"},{"key":"2334_CR74","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/s42003-022-03761-7","volume":"5","author":"N Can\u00e1rio","year":"2022","unstructured":"Can\u00e1rio N, Jorge L, Martins R, Santana I, Castelo-Branco M. Dual PET-fMRI reveals a link between neuroinflammation, amyloid binding and compensatory task-related brain activity in Alzheimer\u2019s disease. Commun Biol. 2022;5:804. https:\/\/doi.org\/10.1038\/s42003-022-03761-7.","journal-title":"Commun Biol"},{"key":"2334_CR75","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cortex.2017.09.018","volume":"97","author":"DT Jones","year":"2017","unstructured":"Jones DT, Graff-Radford J, Lowe VJ, Wiste HJ, Gunter JL, Senjem ML, et al. Tau, amyloid, and cascading network failure across the Alzheimer\u2019s disease spectrum. Cortex. 2017;97:143\u201359. https:\/\/doi.org\/10.1016\/j.cortex.2017.09.018.","journal-title":"Cortex"},{"key":"2334_CR76","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/cercor\/bhu259","volume":"26","author":"JA Elman","year":"2016","unstructured":"Elman JA, Madison CM, Baker SL, Vogel JW, Marks SM, Crowley S, et al. Effects of beta-amyloid on resting state functional connectivity within and between networks reflect known patterns of regional vulnerability. Cereb Cortex. 2016;26:695\u2013707. https:\/\/doi.org\/10.1093\/cercor\/bhu259.","journal-title":"Cereb Cortex"},{"key":"2334_CR77","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/s42003-024-06673-w","volume":"7","author":"A Al-Ezzi","year":"2024","unstructured":"Al-Ezzi A, Arechavala RJ, Butler R, Nolty A, Kang JJ, Shimojo S, et al. Disrupted brain functional connectivity as early signature in cognitively healthy individuals with pathological CSF amyloid\/tau. Commun Biol. 2024;7:1037. https:\/\/doi.org\/10.1038\/s42003-024-06673-w.","journal-title":"Commun Biol"},{"key":"2334_CR78","doi-asserted-by":"publisher","unstructured":"Park J, Kim WJ, Jung HW, Kim JJ, Park JY. Relationship between regional relative theta power and amyloid deposition in mild cognitive impairment: an exploratory study. Front Neurosci. 2025;19. https:\/\/doi.org\/10.3389\/fnins.2025.1510878.","DOI":"10.3389\/fnins.2025.1510878"},{"key":"2334_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-36713-0","volume":"13","author":"NH Kim","year":"2023","unstructured":"Kim NH, Park U, Yang DW, Choi SH, Youn YC, Kang SW. PET-validated EEG-machine learning algorithm predicts brain amyloid pathology in pre-dementia Alzheimer\u2019s disease. Sci Rep. 2023;13:10299. https:\/\/doi.org\/10.1038\/s41598-023-36713-0.","journal-title":"Sci Rep"},{"key":"2334_CR80","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.clinph.2017.05.012","volume":"128","author":"MMA Engels","year":"2017","unstructured":"Engels MMA, van der Flier WM, Stam CJ, Hillebrand A, Scheltens PH, van Straaten ECW. Alzheimer\u2019s disease: the state of the art in resting-state magnetoencephalography. Clin Neurophysiol. 2017;128:1426\u201337. https:\/\/doi.org\/10.1016\/j.clinph.2017.05.012.","journal-title":"Clin Neurophysiol"},{"key":"2334_CR81","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3233\/JAD-180847","volume":"70","author":"LT Eyler","year":"2019","unstructured":"Eyler LT, Elman JA, Hatton SN, Gough S, Mischel AK, Hagler DJ, et al. Resting state abnormalities of the default mode network in mild cognitive impairment: a systematic review and meta-analysis. J Alzheimers Dis. 2019;70:107\u201320. https:\/\/doi.org\/10.3233\/JAD-180847.","journal-title":"J Alzheimers Dis"},{"key":"2334_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28896-3","volume":"13","author":"N Franzmeier","year":"2022","unstructured":"Franzmeier N, Brendel M, Beyer L, Slemann L, Kovacs GG, Arzberger T, et al. Tau deposition patterns are associated with functional connectivity in primary tauopathies. Nat Commun. 2022;13:1362. https:\/\/doi.org\/10.1038\/s41467-022-28896-3.","journal-title":"Nat Commun"},{"key":"2334_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14159-1","volume":"11","author":"N Franzmeier","year":"2020","unstructured":"Franzmeier N, Neitzel J, Rubinski A, Smith R, Strandberg O, Ossenkoppele R, et al. Functional brain architecture is associated with the rate of tau accumulation in Alzheimer\u2019s disease. Nat Commun. 2020;11:347. https:\/\/doi.org\/10.1038\/s41467-019-14159-1.","journal-title":"Nat Commun"},{"key":"2334_CR84","doi-asserted-by":"publisher","first-page":"fcae198","DOI":"10.1093\/braincomms\/fcae198","volume":"6","author":"F Nabizadeh","year":"2024","unstructured":"Nabizadeh F, Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI). Disruption in functional networks mediated tau spreading in Alzheimer\u2019s disease. Brain Commun. 2024;6:fcae198. https:\/\/doi.org\/10.1093\/braincomms\/fcae198.","journal-title":"Brain Commun"},{"key":"2334_CR85","doi-asserted-by":"publisher","first-page":"10325","DOI":"10.1523\/JNEUROSCI.0704-15.2015","volume":"35","author":"L Canuet","year":"2015","unstructured":"Canuet L, Pusil S, L\u00f3pez ME, Bajo R, Pineda-Pardo J\u00c1, Cuesta P, et al. Network disruption and cerebrospinal fluid amyloid-beta and phospho-tau levels in mild cognitive impairment. J Neurosci. 2015;35:10325\u201330. https:\/\/doi.org\/10.1523\/JNEUROSCI.0704-15.2015.","journal-title":"J Neurosci"},{"key":"2334_CR86","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1126\/science.1162844","volume":"321","author":"MA Busche","year":"2008","unstructured":"Busche MA, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold KH, Haass C, et al. Clusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer\u2019s Disease. Science. 2008;321:1686\u20139. https:\/\/doi.org\/10.1126\/science.1162844.","journal-title":"Science"},{"key":"2334_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-022-04268-x","volume":"5","author":"M Algamal","year":"2022","unstructured":"Algamal M, Russ AN, Miller MR, Hou SS, Maci M, Munting LP, et al. Reduced excitatory neuron activity and interneuron-type-specific deficits in a mouse model of Alzheimer\u2019s disease. Commun Biol. 2022;5:1\u20139. https:\/\/doi.org\/10.1038\/s42003-022-04268-x.","journal-title":"Commun Biol"},{"key":"2334_CR88","doi-asserted-by":"publisher","first-page":"8740","DOI":"10.1073\/pnas.1206171109","volume":"109","author":"MA Busche","year":"2012","unstructured":"Busche MA, Chen X, Henning HA, Reichwald J, Staufenbiel M, Sakmann B, et al. Critical role of soluble amyloid-\u03b2 for early hippocampal hyperactivity in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci. 2012;109:8740\u20135. https:\/\/doi.org\/10.1073\/pnas.1206171109.","journal-title":"Proc Natl Acad Sci"},{"key":"2334_CR89","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00429-020-02044-3","volume":"225","author":"H Chung","year":"2020","unstructured":"Chung H, Park K, Jang HJ, Kohl MM, Kwag J. Dissociation of somatostatin and parvalbumin interneurons circuit dysfunctions underlying hippocampal theta and gamma oscillations impaired by amyloid \u03b2 oligomers in vivo. Brain Struct Funct. 2020;225:935\u201354. https:\/\/doi.org\/10.1007\/s00429-020-02044-3.","journal-title":"Brain Struct Funct"},{"key":"2334_CR90","doi-asserted-by":"publisher","unstructured":"Giesers NK, Wirths O. Loss of hippocampal calretinin and parvalbumin interneurons in the 5XFAD mouse model of Alzheimer\u2019s Disease. ASN Neuro. 2020;12: 1759091420925356. https:\/\/doi.org\/10.1177\/1759091420925356.","DOI":"10.1177\/1759091420925356"},{"key":"2334_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18729-5","volume":"8","author":"SQ Ren","year":"2018","unstructured":"Ren SQ, Yao W, Yan JZ, Jin C, Yin JJ, Yuan J, et al. Amyloid \u03b2 causes excitation\/inhibition imbalance through dopamine receptor 1-dependent disruption of fast-spiking GABAergic input in anterior cingulate cortex. Sci Rep. 2018;8:302. https:\/\/doi.org\/10.1038\/s41598-017-18729-5.","journal-title":"Sci Rep"},{"key":"2334_CR92","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.cell.2012.02.046","volume":"149","author":"L Verret","year":"2012","unstructured":"Verret L, Mann EO, Hang GB, Barth AM, Cobos I, Ho K, et al. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer's model. Cell. 2012;149:708\u201321. https:\/\/doi.org\/10.1016\/j.cell.2012.02.046.","journal-title":"Cell"},{"key":"2334_CR93","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1126\/science.aay0198","volume":"365","author":"B Zott","year":"2019","unstructured":"Zott B, Simon MM, Hong W, Unger F, Chen-Engerer HJ, Frosch MP, et al. A vicious cycle of \u03b2 amyloid\u2013dependent neuronal hyperactivation. Science. 2019;365:559\u201365. https:\/\/doi.org\/10.1126\/science.aay0198.","journal-title":"Science"},{"key":"2334_CR94","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/brain\/awz060","volume":"142","author":"MA Busche","year":"2019","unstructured":"Busche MA. Tau suppresses neuronal activity in vivo, even before tangles form. Brain. 2019;142:843\u20136. https:\/\/doi.org\/10.1093\/brain\/awz060.","journal-title":"Brain"},{"key":"2334_CR95","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.neuron.2016.12.023","volume":"93","author":"H Fu","year":"2017","unstructured":"Fu H, Rodriguez GA, Herman M, Emrani S, Nahmani E, Barrett G, et al. Tau pathology induces excitatory neuron loss, grid cell dysfunction, and spatial memory deficits reminiscent of early Alzheimer\u2019s disease. Neuron. 2017;93:533\u2013541.e5. https:\/\/doi.org\/10.1016\/j.neuron.2016.12.023.","journal-title":"Neuron"},{"key":"2334_CR96","doi-asserted-by":"publisher","first-page":"552","DOI":"10.15252\/embr.201541439","volume":"17","author":"JM Decker","year":"2016","unstructured":"Decker JM, Kr\u00fcger L, Sydow A, Dennissen FJ, Siskova Z, Mandelkow E, et al. The Tau\/A152T mutation, a risk factor for frontotemporal-spectrum disorders, leads to NR2B receptor-mediated excitotoxicity. EMBO Rep. 2016;17:552\u201369. https:\/\/doi.org\/10.15252\/embr.201541439.","journal-title":"EMBO Rep"},{"key":"2334_CR97","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1523\/JNEUROSCI.3191-12.2013","volume":"33","author":"JK Holth","year":"2013","unstructured":"Holth JK, Bomben VC, Reed JG, Inoue T, Younkin L, Younkin SG, et al. Tau loss attenuates neuronal network hyperexcitability in mouse and drosophila genetic models of epilepsy. J Neurosci. 2013;33:1651\u20139. https:\/\/doi.org\/10.1523\/JNEUROSCI.3191-12.2013.","journal-title":"J Neurosci"},{"key":"2334_CR98","doi-asserted-by":"publisher","first-page":"530","DOI":"10.15252\/embr.201541438","volume":"17","author":"S Maeda","year":"2016","unstructured":"Maeda S, Djukic B, Taneja P, Yu GQ, Lo I, Davis A, et al. Expression of A152T human tau causes age-dependent neuronal dysfunction and loss in transgenic mice. EMBO Rep. 2016;17:530\u201351. https:\/\/doi.org\/10.15252\/embr.201541438.","journal-title":"EMBO Rep"},{"key":"2334_CR99","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1523\/JNEUROSCI.2880-19.2020","volume":"40","author":"M Shimojo","year":"2020","unstructured":"Shimojo M, Takuwa H, Takado Y, Tokunaga M, Tsukamoto S, Minatohara K, et al. Selective disruption of inhibitory synapses leading to neuronal hyperexcitability at an early stage of tau pathogenesis in a mouse model. J Neurosci. 2020;40:3491\u2013501. https:\/\/doi.org\/10.1523\/JNEUROSCI.2880-19.2020.","journal-title":"J Neurosci"},{"key":"2334_CR100","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.nbd.2017.08.015","volume":"108","author":"SL Angulo","year":"2017","unstructured":"Angulo SL, Orman R, Neymotin SA, Liu L, Buitrago L, et al. Tau and amyloid-related pathologies in the entorhinal cortex have divergent effects in the hippocampal circuit. Neurobiol Dis. 2017;108:261\u201376. https:\/\/doi.org\/10.1016\/j.nbd.2017.08.015.","journal-title":"Neurobiol Dis"},{"key":"2334_CR101","doi-asserted-by":"publisher","first-page":"6221","DOI":"10.1523\/JNEUROSCI.2552-14.2015","volume":"35","author":"AM Hall","year":"2015","unstructured":"Hall AM, Throesch BT, Buckingham SC, Markwardt SJ, Peng Y, Wang Q, et al. Tau-dependent Kv4.2 depletion and dendritic hyperexcitability in a mouse model of Alzheimer\u2019s disease. J Neurosci. 2015;35:6221\u201330. https:\/\/doi.org\/10.1523\/JNEUROSCI.2552-14.2015.","journal-title":"J Neurosci"},{"key":"2334_CR102","doi-asserted-by":"publisher","first-page":"3000851","DOI":"10.1371\/journal.pbio.3000851","volume":"18","author":"GA Rodriguez","year":"2020","unstructured":"Rodriguez GA, Barrett GM, Duff KE, Hussaini SA. Chemogenetic attenuation of neuronal activity in the entorhinal cortex reduces A\u03b2 and tau pathology in the hippocampus. PLoS Biol. 2020;18:3000851. https:\/\/doi.org\/10.1371\/journal.pbio.3000851.","journal-title":"PLoS Biol"},{"key":"2334_CR103","doi-asserted-by":"publisher","first-page":"5557","DOI":"10.1038\/s41380-021-01257-0","volume":"26","author":"LE Arroyo-Garc\u00eda","year":"2021","unstructured":"Arroyo-Garc\u00eda LE, Isla AG, Andrade-Talavera Y, Balleza-Tapia H, Loera-Valencia R, Alvarez-Jimenez L, et al. Impaired spike-gamma coupling of area CA3 fast-spiking interneurons as the earliest functional impairment in the AppNL-G-F mouse model of Alzheimer\u2019s disease. Mol Psychiatry. 2021;26:5557\u201367. https:\/\/doi.org\/10.1038\/s41380-021-01257-0.","journal-title":"Mol Psychiatry"},{"key":"2334_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01444-0","volume":"8","author":"T Nuriel","year":"2017","unstructured":"Nuriel T, Angulo SL, Khan U, Ashok A, Chen Q, Figueroa HY, et al. Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer\u2019s disease-like pathology. Nat Commun. 2017;8:1464. https:\/\/doi.org\/10.1038\/s41467-017-01444-0.","journal-title":"Nat Commun"},{"key":"2334_CR105","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1176\/ajp.2006.163.9.1603","volume":"163","author":"HA Wishart","year":"2006","unstructured":"Wishart HA, Saykin AJ, Rabin LA, Santulli RB, Flashman LA, Guerin SJ, et al. Increased brain activation during working memory in cognitively intact adults with the APOE \u03b54 allele. AJP. 2006;163:1603\u201310. https:\/\/doi.org\/10.1176\/ajp.2006.163.9.1603.","journal-title":"AJP"},{"key":"2334_CR106","doi-asserted-by":"publisher","first-page":"7209","DOI":"10.1073\/pnas.0811879106","volume":"106","author":"N Filippini","year":"2009","unstructured":"Filippini N, MacIntosh BJ, Hough MG, Goodwin GM, Frisoni GB, Smith SM, et al. Distinct patterns of brain activity in young carriers of the APOE-\u03b54 allele. Proc Natl Acad Sci. 2009;106:7209\u201314. https:\/\/doi.org\/10.1073\/pnas.0811879106.","journal-title":"Proc Natl Acad Sci"},{"key":"2334_CR107","doi-asserted-by":"publisher","first-page":"17035","DOI":"10.1523\/JNEUROSCI.3987-10.2010","volume":"30","author":"YI Sheline","year":"2010","unstructured":"Sheline YI, Morris JC, Snyder AZ, Price JL, Yan Z, D'Angelo G, et al. APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF A\u03b242. J Neurosci. 2010;30:17035\u201340. https:\/\/doi.org\/10.1523\/JNEUROSCI.3987-10.2010.","journal-title":"J Neurosci"},{"key":"2334_CR108","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1056\/NEJM200008173430701","volume":"343","author":"SY Bookheimer","year":"2000","unstructured":"Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, et al. Patterns of brain activation in people at risk for Alzheimer\u2019s Disease. N Engl J Med. 2000;343:450\u20136. https:\/\/doi.org\/10.1056\/NEJM200008173430701.","journal-title":"N Engl J Med"},{"key":"2334_CR109","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.neurobiolaging.2006.12.019","volume":"29","author":"NV Ponomareva","year":"2008","unstructured":"Ponomareva NV, Korovaitseva GI, Rogaev EI. EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer's disease. Neurobiol Aging. 2008;29:819\u201327. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2006.12.019.","journal-title":"Neurobiol Aging"},{"key":"2334_CR110","doi-asserted-by":"publisher","first-page":"12587","DOI":"10.1002\/dad2.12587","volume":"16","author":"SJ Schreiner","year":"2024","unstructured":"Schreiner SJ, Van Bergen JMG, Gietl AF, Buck A, Hock C, Pruessmann KP, et al. Gray matter gamma-hydroxy-butyric acid and glutamate reflect beta-amyloid burden at old age. Alzheimer's Dement (Amst. 2024;16:12587. https:\/\/doi.org\/10.1002\/dad2.12587.","journal-title":"Alzheimer's Dement (Amst"},{"key":"2334_CR111","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/hipo.20808","volume":"21","author":"MA Yassa","year":"2011","unstructured":"Yassa MA, Lacy JW, Stark SM, Albert MS, Gallagher M, Stark CEL. Pattern separation deficits associated with increased hippocampal CA3 and dentate gyrus activity in nondemented older adults. Hippocampus. 2011;21:968\u201379. https:\/\/doi.org\/10.1002\/hipo.20808.","journal-title":"Hippocampus"},{"key":"2334_CR112","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1212\/WNL.0b013e3181e3966e","volume":"74","author":"JL O'Brien","year":"2010","unstructured":"O'Brien JL, O'Keefe KM, LaViolette PS, DeLuca AN, Blacker D, Dickerson BC. Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline. Neurology. 2010;74:1969\u201376. https:\/\/doi.org\/10.1212\/WNL.0b013e3181e3966e.","journal-title":"Neurology"},{"key":"2334_CR113","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.3233\/JAD-161291","volume":"58","author":"JF Ochoa","year":"2017","unstructured":"Ochoa JF, Alonso JF, Duque JE, Tob\u00f3n CA, Baena A, Lopera F, et al. Precuneus failures in subjects of the PSEN1 E280A family at risk of developing alzheimer\u2019s disease detected using quantitative electroencephalography. J Alzheimers Dis. 2017;58:1229\u201344. https:\/\/doi.org\/10.3233\/JAD-161291.","journal-title":"J Alzheimers Dis"},{"key":"2334_CR114","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.neurad.2023.09.003","volume":"51","author":"L Velu","year":"2024","unstructured":"Velu L, Pellerin L, Julian A, Paccalin M, Giraud C, Fayolle P, et al. Early rise of glutamate-glutamine levels in mild cognitive impairment: evidence for emerging excitotoxicity. J Neuroradiol. 2024;51:168\u201375. https:\/\/doi.org\/10.1016\/j.neurad.2023.09.003.","journal-title":"J Neuroradiol"},{"key":"2334_CR115","doi-asserted-by":"publisher","first-page":"1220122","DOI":"10.3389\/fnins.2023.1220122","volume":"17","author":"X Fu","year":"2023","unstructured":"Fu X, Qin M, Liu X, Cheng L, Zhang L, Zhang X, et al. Decreased GABA levels of the anterior and posterior cingulate cortex are associated with executive dysfunction in mild cognitive impairment. Front Neurosci. 2023;17:1220122. https:\/\/doi.org\/10.3389\/fnins.2023.1220122.","journal-title":"Front Neurosci"},{"key":"2334_CR116","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.neurobiolaging.2018.09.027","volume":"73","author":"G Oeltzschner","year":"2019","unstructured":"Oeltzschner G, Wijtenburg SA, Mikkelsen M, Edden RAE, Barker PB, Joo JH, et al. Neurometabolites and associations with cognitive deficits in mild cognitive impairment: a magnetic resonance spectroscopy study at 7 Tesla. Neurobiol Aging. 2019;73:211\u20138. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.09.027.","journal-title":"Neurobiol Aging"},{"key":"2334_CR117","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1038\/s41380-019-0483-4","volume":"25","author":"S Hijazi","year":"2020","unstructured":"Hijazi S, Heistek TS, Scheltens P, Neumann U, Shimshek DR, Mansvelder HD, et al. Early restoration of parvalbumin interneuron activity prevents memory loss and network hyperexcitability in a mouse model of Alzheimer\u2019s disease. Mol Psychiatry. 2020;25:3380\u201398. https:\/\/doi.org\/10.1038\/s41380-019-0483-4.","journal-title":"Mol Psychiatry"},{"key":"2334_CR118","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1007\/s00330-016-4669-8","volume":"27","author":"D Huang","year":"2017","unstructured":"Huang D, Liu D, Yin J, Qian T, Shrestha S, Ni H. Glutamate-glutamine and GABA in brain of normal aged and patients with cognitive impairment. Eur Radio. 2017;27:2698\u2013705. https:\/\/doi.org\/10.1007\/s00330-016-4669-8.","journal-title":"Eur Radio"},{"key":"2334_CR119","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.clinph.2021.03.050","volume":"132","author":"AA Horvath","year":"2021","unstructured":"Horvath AA, Papp A, Zsuffa J, Szucs A, Luckl J, Radai F, et al. Subclinical epileptiform activity accelerates the progression of Alzheimer\u2019s disease: a long-term EEG study. Clin Neurophysiol. 2021;132:1982\u20139. https:\/\/doi.org\/10.1016\/j.clinph.2021.03.050.","journal-title":"Clin Neurophysiol"},{"key":"2334_CR120","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nm.4330","volume":"23","author":"AD Lam","year":"2017","unstructured":"Lam AD, Deck G, Goldman A, Eskandar EN, Noebels J, Cole AJ. Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer\u2019s disease. Nat Med. 2017;23:678\u201380. https:\/\/doi.org\/10.1038\/nm.4330.","journal-title":"Nat Med"},{"key":"2334_CR121","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1001\/jamaneurol.2013.136","volume":"70","author":"KA Vossel","year":"2013","unstructured":"Vossel KA, Beagle AJ, Rabinovici GD, Shu H, Lee SE, Naasan G, et al. Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol. 2013;70:1158\u201366. https:\/\/doi.org\/10.1001\/jamaneurol.2013.136.","journal-title":"JAMA Neurol"},{"key":"2334_CR122","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/ana.24794","volume":"80","author":"KA Vossel","year":"2016","unstructured":"Vossel KA, Ranasinghe KG, Beagle AJ, Mizuiri D, Honma SM, Dowling AF, et al. Incidence and impact of subclinical epileptiform activity in Alzheimer\u2019s disease. Ann Neurol. 2016;80:858\u201370. https:\/\/doi.org\/10.1002\/ana.24794.","journal-title":"Ann Neurol"},{"key":"2334_CR123","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00401-022-02526-0","volume":"145","author":"P Scaduto","year":"2023","unstructured":"Scaduto P, Lauterborn JC, Cox CD, Fracassi A, Zeppillo T, Gutierrez BA, et al. Functional excitatory to inhibitory synaptic imbalance and loss of cognitive performance in people with Alzheimer\u2019s disease neuropathologic change. Acta Neuropathol. 2023;145:303\u201324. https:\/\/doi.org\/10.1007\/s00401-022-02526-0.","journal-title":"Acta Neuropathol"},{"key":"2334_CR124","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fnhum.2016.00238","volume":"10","author":"MM Engels","year":"2016","unstructured":"Engels MM, Hillebrand A, van der Flier WM, Stam CJ, Scheltens P, van Straaten EC. Slowing of hippocampal activity correlates with cognitive decline in early onset Alzheimer\u2019s disease. An MEG study with virtual electrodes. Front Hum Neurosci. 2016;10:238. https:\/\/doi.org\/10.3389\/fnhum.2016.00238.","journal-title":"Front Hum Neurosci"},{"key":"2334_CR125","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/WNP.0b013e31817da184","volume":"25","author":"W de Haan","year":"2008","unstructured":"de Haan W, Stam CJ, Jones BF, Zuiderwijk IM, van Dijk BW, Scheltens P. Resting-state oscillatory brain dynamics in Alzheimer's disease. J Clin Neurophysiol. 2008;25:187\u201393. https:\/\/doi.org\/10.1097\/WNP.0b013e31817da184.","journal-title":"J Clin Neurophysiol"},{"key":"2334_CR126","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-020-00382-8","volume":"15","author":"R Larramona-Arcas","year":"2020","unstructured":"Larramona-Arcas R, Gonz\u00e1lez-Arias C, Perea G, Guti\u00e9rrez A, Vitorica J, Garc\u00eda-Barrera T, et al. Sex-dependent calcium hyperactivity due to lysosomal-related dysfunction in astrocytes from APOE4 versus APOE3 gene-targeted replacement mice. Mol Neurodegener. 2020;15:35. https:\/\/doi.org\/10.1186\/s13024-020-00382-8.","journal-title":"Mol Neurodegener"},{"key":"2334_CR127","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.stem.2009.10.015","volume":"5","author":"G Li","year":"2009","unstructured":"Li G, Bien-Ly N, Andrews-Zwilling Y, Xu Q, Bernardo A, Ring K, et al. GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice. Cell Stem Cell. 2009;5:634\u201345. https:\/\/doi.org\/10.1016\/j.stem.2009.10.015.","journal-title":"Cell Stem Cell"},{"key":"2334_CR128","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s12035-023-03556-9","volume":"61","author":"SB Scheinman","year":"2024","unstructured":"Scheinman SB, Tseng KY, Alford S, Tai LM. Higher neuronal facilitation and potentiation with APOE4 suppressed by angiotensin II. Mol Neurobiol. 2024;61:120\u201331. https:\/\/doi.org\/10.1007\/s12035-023-03556-9.","journal-title":"Mol Neurobiol"},{"key":"2334_CR129","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1523\/JNEUROSCI.1897-18.2018","volume":"39","author":"A Jain","year":"2019","unstructured":"Jain A, Huang GZ, Woolley CS. Latent sex differences in molecular signaling that underlies excitatory synaptic potentiation in the hippocampus. J Neurosci. 2019;39:1552\u201365. https:\/\/doi.org\/10.1523\/JNEUROSCI.1897-18.2018.","journal-title":"J Neurosci"},{"key":"2334_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-62820-7","volume":"14","author":"L Mosconi","year":"2024","unstructured":"Mosconi L, Nerattini M, Matthews DC, Jett S, Andy C, Williams S, et al. In vivo brain estrogen receptor density by neuroendocrine aging and relationships with cognition and symptomatology. Sci Rep. 2024;14:12680. https:\/\/doi.org\/10.1038\/s41598-024-62820-7.","journal-title":"Sci Rep"},{"key":"2334_CR131","doi-asserted-by":"publisher","first-page":"11252","DOI":"10.1523\/JNEUROSCI.1067-15.2015","volume":"35","author":"N Tabatadze","year":"2015","unstructured":"Tabatadze N, Huang G, May RM, Jain A, Woolley CS. Sex differences in molecular signaling at inhibitory synapses in the hippocampus. J Neurosci. 2015;35:11252. https:\/\/doi.org\/10.1523\/JNEUROSCI.1067-15.2015.","journal-title":"J Neurosci"},{"key":"2334_CR132","doi-asserted-by":"publisher","first-page":"105370","DOI":"10.1016\/j.neubiorev.2023.105370","volume":"153","author":"DJ Terstege","year":"2023","unstructured":"Terstege DJ, Epp JR. Parvalbumin as a sex-specific target in Alzheimer\u2019s disease research\u2014a mini-review. Neurosci Biobehav Rev. 2023;153:105370. https:\/\/doi.org\/10.1016\/j.neubiorev.2023.105370.","journal-title":"Neurosci Biobehav Rev"},{"key":"2334_CR133","doi-asserted-by":"publisher","first-page":"eaba3066","DOI":"10.1126\/science.aba3066","volume":"369","author":"M Oliva","year":"2020","unstructured":"Oliva M, Mu\u00f1oz-Aguirre M, Kim-Hellmuth S, Wucher V, Gewirtz ADH, Cotter DJ, et al. The impact of sex on gene expression across human tissues. Science. 2020;369:eaba3066. https:\/\/doi.org\/10.1126\/science.aba3066.","journal-title":"Science"},{"key":"2334_CR134","doi-asserted-by":"publisher","first-page":"101804","DOI":"10.1016\/j.arr.2022.101804","volume":"83","author":"S Hafizi","year":"2023","unstructured":"Hafizi S, Rajji TK. Modifiable risk factors of dementia linked to excitation-inhibition imbalance. Ageing Res Rev. 2023;83:101804. https:\/\/doi.org\/10.1016\/j.arr.2022.101804.","journal-title":"Ageing Res Rev"},{"key":"2334_CR135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-022-02024-7","volume":"12","author":"H Targa Dias Anastacio","year":"2022","unstructured":"Targa Dias Anastacio H, Matosin N, Ooi L. Neuronal hyperexcitability in Alzheimer\u2019s disease: what are the drivers behind this aberrant phenotype?. Transl Psychiatry. 2022;12:1\u201314. https:\/\/doi.org\/10.1038\/s41398-022-02024-7.","journal-title":"Transl Psychiatry"},{"key":"2334_CR136","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1089\/ars.2018.7509","volume":"28","author":"R Franco","year":"2018","unstructured":"Franco R, Vargas MR. Redox biology in neurological function, dysfunction, and aging. Antioxid Redox Signal. 2018;28:1583\u20136. https:\/\/doi.org\/10.1089\/ars.2018.7509.","journal-title":"Antioxid Redox Signal"},{"key":"2334_CR137","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.neuroscience.2019.05.064","volume":"439","author":"AN Beltr\u00e1n Gonz\u00e1lez","year":"2020","unstructured":"Beltr\u00e1n Gonz\u00e1lez AN, L\u00f3pez Pazos MI, Calvo DJ. Reactive oxygen species in the regulation of the GABA-mediated Inhibitory neurotransmission. Neuroscience. 2020;439:137\u201345. https:\/\/doi.org\/10.1016\/j.neuroscience.2019.05.064.","journal-title":"Neuroscience"},{"key":"2334_CR138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0014-5793(01)02437-1","volume":"497","author":"A Atlante","year":"2001","unstructured":"Atlante A, Calissano P, Bobba A, Giannattasio S, Marra E, Passarella S. Glutamate neurotoxicity, oxidative stress and mitochondria. FEBS Lett. 2001;497:1\u20135. https:\/\/doi.org\/10.1016\/S0014-5793(01)02437-1.","journal-title":"FEBS Lett"},{"key":"2334_CR139","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s40572-018-0209-9","volume":"5","author":"P de Prado Bert","year":"2018","unstructured":"de Prado Bert P, Mercader EMH, Pujol J, Sunyer J, Mortamais M. The effects of air pollution on the brain: a review of studies interfacing environmental epidemiology and neuroimaging. Curr Environ Health Rep. 2018;5:351\u201364. https:\/\/doi.org\/10.1007\/s40572-018-0209-9.","journal-title":"Curr Environ Health Rep"},{"key":"2334_CR140","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.3390\/ijms21093165","volume":"21","author":"TT Nguyen","year":"2020","unstructured":"Nguyen TT, Ta QTH, Nguyen TKO, Nguyen TTD, Giau VV. Type 3 diabetes and its role implications in Alzheimer\u2019s Disease. Int J Mol Sci. 2020;21:3165. https:\/\/doi.org\/10.3390\/ijms21093165.","journal-title":"Int J Mol Sci"},{"key":"2334_CR141","doi-asserted-by":"publisher","first-page":"11955","DOI":"10.3390\/ijms252211955","volume":"25","author":"M Kciuk","year":"2024","unstructured":"Kciuk M, Kruczkowska W, Ga\u0142\u0119ziewska J, Wanke K, Ka\u0142uzi\u0144ska-Ko\u0142at \u017b, Aleksandrowicz M, et al. Alzheimer\u2019s Disease as type 3 diabetes: understanding the link and implications. Int J Mol Sci. 2024;25:11955. https:\/\/doi.org\/10.3390\/ijms252211955.","journal-title":"Int J Mol Sci"},{"key":"2334_CR142","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.2337\/db20-1119","volume":"70","author":"W Cai","year":"2021","unstructured":"Cai W, Zhang X, Batista TM, Garc\u00eda-Mart\u00edn R, Softic S, Wang G, et al. Peripheral insulin regulates a broad network of gene expression in hypothalamus, hippocampus, and nucleus accumbens. Diabetes. 2021;70:1857\u201373. https:\/\/doi.org\/10.2337\/db20-1119.","journal-title":"Diabetes"},{"key":"2334_CR143","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","volume":"14","author":"SE Arnold","year":"2018","unstructured":"Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang HY, Ahima RS, et al. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol. 2018;14:168\u201381. https:\/\/doi.org\/10.1038\/nrneurol.2017.185.","journal-title":"Nat Rev Neurol"},{"key":"2334_CR144","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.acra.2012.02.004","volume":"19","author":"M Petrou","year":"2012","unstructured":"Petrou M, Pop-Busui R, Foerster BR, Edden RA, Callaghan BC, Harte SE, et al. Altered excitation-inhibition balance in the brain of patients with diabetic neuropathy. Acad Radiol. 2012;19:607\u201312. https:\/\/doi.org\/10.1016\/j.acra.2012.02.004.","journal-title":"Acad Radiol"},{"key":"2334_CR145","doi-asserted-by":"publisher","first-page":"e00421","DOI":"10.1042\/BSR20160437","volume":"36","author":"M Larsson","year":"2016","unstructured":"Larsson M, Lietzau G, Nathanson D, \u00d6stenson CG, Mallard C, Johansson ME, et al. Diabetes negatively affects cortical and striatal GABAergic neurons: an effect that is partially counteracted by exendin-4. Biosci Rep. 2016;36:e00421. https:\/\/doi.org\/10.1042\/BSR20160437.","journal-title":"Biosci Rep"},{"key":"2334_CR146","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1001\/archgenpsychiatry.2009.86","volume":"66","author":"IK Lyoo","year":"2009","unstructured":"Lyoo IK, Yoon SJ, Musen G, Simonson DC, Weinger K, Bolo N, et al. Altered prefrontal glutamate\u2013glutamine\u2013\u03b3-aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus. Arch Gen Psychiatry. 2009;66:878\u201387. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2009.86.","journal-title":"Arch Gen Psychiatry"},{"key":"2334_CR147","doi-asserted-by":"publisher","first-page":"7605","DOI":"10.1158\/0008-5472.CAN-07-1100","volume":"67","author":"MY Chang","year":"2007","unstructured":"Chang MY, Boulden J, Katz JB, Wang L, Meyer TJ, Soler AP, et al. Bin1 ablation increases susceptibility to cancer during aging, particularly lung cancer. Cancer Res. 2007;67:7605\u201312. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-1100.","journal-title":"Cancer Res"},{"key":"2334_CR148","doi-asserted-by":"publisher","first-page":"e57354","DOI":"10.7554\/eLife.57354","volume":"9","author":"Y Voskobiynyk","year":"2020","unstructured":"Voskobiynyk Y, Roth JR, Cochran JN, Rush T, Carullo NV, Mesina JS, et al. Alzheimer\u2019s disease risk gene BIN1 induces Tau-dependent network hyperexcitability. Zoghbi HY, Fryer JD, Reed M, Kraemer B, eds. eLife. 2020;9:e57354. https:\/\/doi.org\/10.7554\/eLife.57354.","journal-title":"eLife"},{"key":"2334_CR149","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.tins.2012.11.008","volume":"36","author":"O Devinsky","year":"2013","unstructured":"Devinsky O, Vezzani A, Najjar S, De Lanerolle NC, Rogawski MA. Glia and epilepsy: excitability and inflammation. Trends Neurosci. 2013;36:174\u201384. https:\/\/doi.org\/10.1016\/j.tins.2012.11.008.","journal-title":"Trends Neurosci"},{"key":"2334_CR150","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/ana.20358","volume":"57","author":"C Dub\u00e9","year":"2005","unstructured":"Dub\u00e9 C, Vezzani A, Behrens M, Bartfai T, Baram TZ. Interleukin-1\u03b2 contributes to the generation of experimental febrile seizures. Ann Neurol. 2005;57:152\u20135. https:\/\/doi.org\/10.1002\/ana.20358.","journal-title":"Ann Neurol"},{"key":"2334_CR151","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/j.1528-1167.2006.00590.x","volume":"47","author":"T Ravizza","year":"2006","unstructured":"Ravizza T, Lucas SM, Balosso S, Bernardino L, Ku G, No\u00e9 F, et al. Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy. Epilepsia. 2006;47:1160\u20138. https:\/\/doi.org\/10.1111\/j.1528-1167.2006.00590.x.","journal-title":"Epilepsia"},{"key":"2334_CR152","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1093\/brain\/awn271","volume":"131","author":"S Balosso","year":"2008","unstructured":"Balosso S, Maroso M, Sanchez-Alavez M, Ravizza T, Frasca A, Bartfai T, et al. A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1\u03b2. Brain. 2008;131:3256\u201365. https:\/\/doi.org\/10.1093\/brain\/awn271.","journal-title":"Brain"},{"key":"2334_CR153","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1126\/science.1067859","volume":"295","author":"EC Beattie","year":"2002","unstructured":"Beattie EC, Stellwagen D, Morishita W, Bresnahan JC, Ha BK, Von Zastrow M, et al. Control of synaptic strength by glial TNF\u03b1. Science. 2002;295:2282\u20135. https:\/\/doi.org\/10.1126\/science.1067859.","journal-title":"Science"},{"key":"2334_CR154","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.neuron.2011.02.003","volume":"69","author":"M Santello","year":"2011","unstructured":"Santello M, Bezzi P, Volterra A. TNF\u03b1 controls glutamatergic gliotransmission in the hippocampal dentate gyrus. Neuron. 2011;69:988\u20131001. https:\/\/doi.org\/10.1016\/j.neuron.2011.02.003.","journal-title":"Neuron"},{"key":"2334_CR155","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1093\/brain\/awy247","volume":"141","author":"F Frigerio","year":"2018","unstructured":"Frigerio F, Pasqualini G, Craparotta I, Marchini S, van Vliet EA, Foerch P, et al. n-3 Docosapentaenoic acid-derived protectin D1 promotes resolution of neuroinflammation and arrests epileptogenesis. Brain. 2018;141:3130\u201343. https:\/\/doi.org\/10.1093\/brain\/awy247.","journal-title":"Brain"},{"key":"2334_CR156","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/epi.13387","volume":"57","author":"S Lagarde","year":"2016","unstructured":"Lagarde S, Villeneuve N, Tr\u00e9buchon A, Kaphan E, Lepine A, McGonigal A, et al. Anti\u2013tumor necrosis factor alpha therapy (adalimumab) in Rasmussen\u2019s encephalitis: an open pilot study. Epilepsia. 2016;57:956\u201366. https:\/\/doi.org\/10.1111\/epi.13387.","journal-title":"Epilepsia"},{"key":"2334_CR157","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1084\/jem.20041611","volume":"201","author":"K Takahashi","year":"2005","unstructured":"Takahashi K, Rochford CDP, Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med. 2005;201:647\u201357. https:\/\/doi.org\/10.1084\/jem.20041611.","journal-title":"J Exp Med"},{"key":"2334_CR158","doi-asserted-by":"publisher","unstructured":"Lenz KM, Nelson LH. Microglia and beyond: innate immune cells as regulators of brain development and behavioral function. Front Immunol. 2018;9. https:\/\/doi.org\/10.3389\/fimmu.2018.00698.","DOI":"10.3389\/fimmu.2018.00698"},{"key":"2334_CR159","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1002\/glia.23961","volume":"69","author":"AD Umpierre","year":"2021","unstructured":"Umpierre AD, Wu LJ. How microglia sense and regulate neuronal activity. Glia. 2021;69:1637\u201353. https:\/\/doi.org\/10.1002\/glia.23961.","journal-title":"Glia"},{"key":"2334_CR160","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bbi.2020.06.028","volume":"89","author":"W Wu","year":"2020","unstructured":"Wu W, Li Y, Wei Y, Bosco DB, Xie M, Zhao MG, et al. Microglial depletion aggravates the severity of acute and chronic seizures in mice. Brain Behav Immun. 2020;89:245\u201355. https:\/\/doi.org\/10.1016\/j.bbi.2020.06.028.","journal-title":"Brain Behav Immun"},{"key":"2334_CR161","doi-asserted-by":"publisher","unstructured":"Akiyoshi R, Wake H, Kato D, Horiuchi H, Ono R, Ikegami A, et al. Microglia enhance synapse activity to promote local network synchronization. eNeuro. 2018;5. https:\/\/doi.org\/10.1523\/ENEURO.0088-18.2018.","DOI":"10.1523\/ENEURO.0088-18.2018"},{"key":"2334_CR162","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.neuroscience.2004.06.008","volume":"129","author":"P Kofuji","year":"2004","unstructured":"Kofuji P, Newman EA. Potassium buffering in the central nervous system. Neuroscience. 2004;129:1043\u201354. https:\/\/doi.org\/10.1016\/j.neuroscience.2004.06.008.","journal-title":"Neuroscience"},{"key":"2334_CR163","doi-asserted-by":"publisher","first-page":"980","DOI":"10.4103\/1673-5374.270295","volume":"15","author":"F Wang","year":"2020","unstructured":"Wang F, Qi X, Zhang J, Huang JH. Astrocytic modulation of potassium under seizures. Neural Regener Res. 2020;15:980. https:\/\/doi.org\/10.4103\/1673-5374.270295.","journal-title":"Neural Regener Res"},{"key":"2334_CR164","unstructured":"Alterations in Expression of Glutamatergic Transporters and Receptors in Sporadic Alzheimer\u2019s Disease - C.P, Jacob, E, Koutsilieri, J, Bartl, E, Neuen-Jacob, T, Arzberger, N, et al. Gr\u00fcnblatt, 2007. Accessed July 26, 2025. https:\/\/journals-sagepub-com.ezproxy.library.wisc.edu\/doi\/10.3233\/jad-2007-11113?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed."},{"key":"2334_CR165","doi-asserted-by":"publisher","first-page":"553.e1","DOI":"10.1016\/j.neurobiolaging.2010.03.008","volume":"32","author":"HA Scott","year":"2011","unstructured":"Scott HA, Gebhardt FM, Mitrovic AD, Vandenberg RJ, Dodd PR. Glutamate transporter variants reduce glutamate uptake in Alzheimer\u2019s disease. Neurobiol Aging. 2011;32:553.e1\u2013553.e11. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.03.008.","journal-title":"Neurobiol Aging"},{"key":"2334_CR166","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1097\/00005072-199708000-00008","volume":"56","author":"S Li","year":"1997","unstructured":"Li S, Mallory M, Alford M, Tanaka S, Masliah E. Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression. J Neuropathol Exp Neurol. 1997;56:901\u201311. https:\/\/doi.org\/10.1097\/00005072-199708000-00008.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2334_CR167","doi-asserted-by":"publisher","first-page":"81828","DOI":"10.1371\/journal.pone.0081828","volume":"8","author":"TM Pirttimaki","year":"2013","unstructured":"Pirttimaki TM, Codadu NK, Awni A, Pratik P, Nagel DA, Hill EJ, et al. \u03b17 Nicotinic receptor-mediated astrocytic gliotransmitter release: A\u03b2 effects in a preclinical Alzheimer\u2019s mouse model. PLOS ONE. 2013;8:81828. https:\/\/doi.org\/10.1371\/journal.pone.0081828.","journal-title":"PLOS ONE"},{"key":"2334_CR168","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bcp.2009.09.014","volume":"79","author":"A Buffo","year":"2010","unstructured":"Buffo A, Rolando C, Ceruti S. Astrocytes in the damaged brain: Molecular and cellular insights into their reactive response and healing potential. Biochem Pharmacol. 2010;79:77\u201389. https:\/\/doi.org\/10.1016\/j.bcp.2009.09.014.","journal-title":"Biochem Pharmacol"},{"key":"2334_CR169","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nn.2535","volume":"13","author":"PI Ortinski","year":"2010","unstructured":"Ortinski PI, Dong J, Mungenast A, Yue C, Takano H, Watson DJ, et al. Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat Neurosci. 2010;13:584\u201391. https:\/\/doi.org\/10.1038\/nn.2535.","journal-title":"Nat Neurosci"},{"key":"2334_CR170","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.celrep.2015.04.017","volume":"11","author":"K Yamamoto","year":"2015","unstructured":"Yamamoto K, Tanei ZI, Hashimoto T, Wakabayashi T, Okuno H, Naka Y, et al. Chronic optogenetic activation augments A\u03b2 pathology in a mouse model of Alzheimer Disease. Cell Rep. 2015;11:859\u201365. https:\/\/doi.org\/10.1016\/j.celrep.2015.04.017.","journal-title":"Cell Rep"},{"key":"2334_CR171","doi-asserted-by":"publisher","unstructured":"Traikapi A, Konstantinou N. Gamma oscillations in Alzheimer\u2019s Disease and their potential therapeutic role. Front Syst Neurosci. 2021;15. https:\/\/doi.org\/10.3389\/fnsys.2021.782399.","DOI":"10.3389\/fnsys.2021.782399"},{"key":"2334_CR172","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1038\/s41380-022-01444-7","volume":"27","author":"A Majdi","year":"2022","unstructured":"Majdi A, van Boekholdt L, Sadigh-Eteghad S, Mc Laughlin M. A systematic review and meta-analysis of transcranial direct-current stimulation effects on cognitive function in patients with Alzheimer\u2019s disease. Mol Psychiatry. 2022;27:2000\u20139. https:\/\/doi.org\/10.1038\/s41380-022-01444-7.","journal-title":"Mol Psychiatry"},{"key":"2334_CR173","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-024-00423-y","volume":"13","author":"ML De Paolis","year":"2024","unstructured":"De Paolis ML, Paoletti I, Zaccone C, Capone F, D'amelio M, Krashia P. Transcranial alternating current stimulation (tACS) at gamma frequency: an up-and-coming tool to modify the progression of Alzheimer\u2019s Disease. Transl Neurodegener. 2024;13:33. https:\/\/doi.org\/10.1186\/s40035-024-00423-y.","journal-title":"Transl Neurodegener"},{"key":"2334_CR174","doi-asserted-by":"publisher","unstructured":"Weiler M, Stieger KC, Long JM, Rapp PR. Transcranial magnetic stimulation in alzheimer\u2019s disease: are we ready? eNeuro. 2020;7:ENEURO.0235-19.2019. https:\/\/doi.org\/10.1523\/ENEURO.0235-19.2019.","DOI":"10.1523\/ENEURO.0235-19.2019"},{"key":"2334_CR175","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.wneu.2023.12.083","volume":"184","author":"B Picton","year":"2024","unstructured":"Picton B, Wong J, Lopez AM, Solomon SS, Andalib S, Brown NJ, et al. Deep brain stimulation as an emerging therapy for cognitive decline in Alzheimer Disease: systematic review of evidence and current targets. World Neurosurg. 2024;184:253\u201366. https:\/\/doi.org\/10.1016\/j.wneu.2023.12.083.","journal-title":"World Neurosurg"},{"key":"2334_CR176","unstructured":"Kumar A, Maini K, Kadian R. Levetiracetam. In: StatPearls. StatPearls Publishing; Accessed June 23, 2025. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK499890\/ 2025"},{"key":"2334_CR177","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.neuron.2012.03.023","volume":"74","author":"A Bakker","year":"2012","unstructured":"Bakker A, Krauss GL, Albert MS, Speck CL, Jones LR, Stark CE, et al. Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron. 2012;74:467\u201374. https:\/\/doi.org\/10.1016\/j.neuron.2012.03.023.","journal-title":"Neuron"},{"key":"2334_CR178","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.nicl.2015.02.009","volume":"7","author":"A Bakker","year":"2015","unstructured":"Bakker A, Albert MS, Krauss G, Speck CL, Gallagher M. Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task performance. Neuroimage Clin. 2015;7:688\u201398. https:\/\/doi.org\/10.1016\/j.nicl.2015.02.009.","journal-title":"Neuroimage Clin"},{"key":"2334_CR179","doi-asserted-by":"publisher","first-page":"12446","DOI":"10.1002\/trc2.12446","volume":"10","author":"R Mohs","year":"2024","unstructured":"Mohs R, Bakker A, Rosenzweig-Lipson S, Rosenblum M, Barton RL, Albert MS, et al. The HOPE4MCI study: a randomized double-blind assessment of AGB101 for the treatment of MCI due to AD. Alzheimer's Dement. 2024;10:12446. https:\/\/doi.org\/10.1002\/trc2.12446.","journal-title":"Alzheimer's Dement"},{"key":"2334_CR180","doi-asserted-by":"publisher","first-page":"70004","DOI":"10.1002\/trc2.70004","volume":"10","author":"A Bakker","year":"2024","unstructured":"Bakker A, Rani N, Mohs R, Gallagher M. The HOPE4MCI study: AGB101 treatment slows progression of entorhinal cortex atrophy in APOE \u03b54 non-carriers with mild cognitive impairment due to Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2024;10:70004. https:\/\/doi.org\/10.1002\/trc2.70004.","journal-title":"Alzheimer\u2019s Dement"},{"key":"2334_CR181","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.yebeh.2010.01.015","volume":"17","author":"E Cumbo","year":"2010","unstructured":"Cumbo E, Ligori LD. Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer\u2019s disease. Epilepsy Behav. 2010;17:461\u20136. https:\/\/doi.org\/10.1016\/j.yebeh.2010.01.015.","journal-title":"Epilepsy Behav"},{"key":"2334_CR182","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05404-4","volume":"22","author":"A Sen","year":"2021","unstructured":"Sen A, Akinola M, Tai XY, Symmonds M, Davis Jones G, Mura S, et al. An Investigation of Levetiracetam in Alzheimer\u2019s Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study. Trials. 2021;22:508. https:\/\/doi.org\/10.1186\/s13063-021-05404-4.","journal-title":"Trials"},{"key":"2334_CR183","doi-asserted-by":"publisher","unstructured":"Sen A, Toniolo S, Tai XY, Akinola M, Symmonds M, Mura S, et al. Safety, tolerability and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer\u2019s Disease (ILiAD) trial. Epilepsia Open. 2024;9:2353\u201364. https:\/\/doi.org\/10.1002\/epi4.13070.","DOI":"10.1002\/epi4.13070"},{"key":"2334_CR184","doi-asserted-by":"publisher","unstructured":"Vossel K, Ranasinghe KG, Beagle AJ, La A, Ah Pook K, Castro M, et al. Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity. JAMA Neurol. 2021;78:1\u201310. https:\/\/doi.org\/10.1001\/jamaneurol.2021.3310.","DOI":"10.1001\/jamaneurol.2021.3310"},{"key":"2334_CR185","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1021\/acs.jproteome.1c00180","volume":"20","author":"NR Rao","year":"2021","unstructured":"Rao NR, Savas JN. Levetiracetam treatment normalizes levels of presynaptic endocytosis machinery and restores nonamyloidogenic APP processing in App knock-in mice. J Proteome Res. 2021;20:3580\u20139. https:\/\/doi.org\/10.1021\/acs.jproteome.1c00180.","journal-title":"J Proteome Res"},{"key":"2334_CR186","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1073\/pnas.1121081109","volume":"109","author":"PE Sanchez","year":"2012","unstructured":"Sanchez PE, Zhu L, Verret L, Vossel KA, Orr AG, Cirrito JR, et al. Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer\u2019s disease model. Proc Natl Acad Sci. 2012;109:2895\u2013903. https:\/\/doi.org\/10.1073\/pnas.1121081109.","journal-title":"Proc Natl Acad Sci"},{"key":"2334_CR187","doi-asserted-by":"publisher","first-page":"888784","DOI":"10.3389\/fnagi.2022.888784","volume":"14","author":"XY Zheng","year":"2022","unstructured":"Zheng XY, Zhang HC, Lv YD, Jin FY, Wu XJ, Zhu J, et al. Levetiracetam alleviates cognitive decline in Alzheimer\u2019s disease animal model by ameliorating the dysfunction of the neuronal network. Front Aging Neurosci. 2022;14:888784. https:\/\/doi.org\/10.3389\/fnagi.2022.888784.","journal-title":"Front Aging Neurosci"},{"key":"2334_CR188","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.3390\/biomedicines12122891","volume":"12","author":"JC Thompson","year":"2024","unstructured":"Thompson JC, Levis Rabi M, Novoa M, Nash KR, Joly-Amado A. Evaluating the efficacy of levetiracetam on non-cognitive symptoms and pathology in a Tau mouse model. Biomedicines. 2024;12:2891. https:\/\/doi.org\/10.3390\/biomedicines12122891.","journal-title":"Biomedicines"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02334-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02334-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02334-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T17:24:04Z","timestamp":1768843444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02334-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":188,"alternative-id":["2334"],"URL":"https:\/\/doi.org\/10.1038\/s41386-026-02334-0","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: AL is a cofounder of KeyWise and a scientific advisor to Buoy Health and OTSUKA US. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}